TechLink Facebook Twitter Linkedin Search File Previous Next Arrow Right Materials Sensors Medical Biotechnology Millitary Tech Photonics Communications Electronics Energy Environmental Software Information and Technology Other Technologies Double Arrow Left

Army

Combinations of gene deletions for live attenuated Shigella vaccine strains

  • US Patent No. 8986708
  • Issued: March 24, 2015
  • Status: Active
Medical & Biotechnology

Shigella vaccine strains whose primary attenuating feature is deletion of the virG(icsA) gene and additional two or more deletions in setAB(shET1), senA(shET2), senB(shET2-2), stxAB, and msbB2 genes. Thus, the vaccine strain will have three or more deletions in the identified genes, will be safer, and will reduce or eliminate symptoms of fever and diarrhea in humans. The following specific vaccine strains have been constructed: WRSS3 (ΔsenA, ΔsenB, ΔvirG, ΔmsbB2), WRSf2G15 (ΔvirG, ΔsetAB, ΔsenA, ΔsenB, ΔmsbB2), and WRSd5 (ΔvirG, ΔstxAB, ΔsenA, ΔsenB, ΔmsbB2).

Do you have questions or need more information on a specific technology? Let's talk.

Contact Us